VANIQA (Allergan, Inc.)
Welcome to the PulseAid listing for the VANIQA drug offered from Allergan, Inc.. This Antiprotozoal [EPC],Decarboxylase Inhibitor [EPC],Decarboxylase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | eflornithine hydrochloride |
| SUBSTANCE NAME: | EFLORNITHINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antiprotozoal [EPC],Decarboxylase Inhibitor [EPC],Decarboxylase Inhibitors [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-06-01 |
| END MARKETING DATE: | 0000-00-00 |
VANIQA HUMAN PRESCRIPTION DRUG Details:
| Item Description | VANIQA from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 139(mg/g) |
| START MARKETING DATE: | 2013-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-4857_0cabbfd5-ec30-44a9-9f64-2532fa0cfe07 |
| PRODUCT NDC: | 0023-4857 |
| APPLICATION NUMBER: | NDA021145 |
Other EFLORNITHINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
